These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6137965)
1. Another view of calcium and extrapyramidal side effects. Bailie GR; Nelson MV; Lesar T Am J Psychiatry; 1983 Nov; 140(11):1537-8. PubMed ID: 6137965 [No Abstract] [Full Text] [Related]
2. Calcium and extrapyramidal side effects. El-Defrawi MH Am J Psychiatry; 1982 Aug; 139(8):1079. PubMed ID: 6124137 [No Abstract] [Full Text] [Related]
3. [The effect of dexbenzetimide (Tremblex - Gedeon Richter) on postneuroleptic extrapyramidal syndromes (author's transl)]. Firko M; Morasiewicz J; Puchała G Psychiatr Pol; 1981; 15(2):139-44. PubMed ID: 6118905 [No Abstract] [Full Text] [Related]
4. Calcium therapy for neuroleptic-induced extrapyramidal symptoms. Fernando ML; Manchanda R Br J Psychiatry; 1988 May; 152():722-3. PubMed ID: 2901889 [No Abstract] [Full Text] [Related]
5. Fluphenazine-induced extrapyramidal side effects in a horse. Brashier M Vet Clin North Am Equine Pract; 2006 Apr; 22(1):e37-45. PubMed ID: 16627093 [No Abstract] [Full Text] [Related]
6. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. McEvoy JP J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370 [TBL] [Abstract][Full Text] [Related]
9. [Use of the methylxanthines, caffeine and theophylline, in the treatment of extrapyramidal disorders caused by treatment with neuroleptics. Development of a therapeutic hypothesis]. Casas M; Torrens M; Duro P; Pinet C; Alvarez E; Udina C Encephale; 1989; 15 Spec No():177-80. PubMed ID: 2568253 [No Abstract] [Full Text] [Related]
10. [Correction of an extrapyramidal neuroleptic syndrome with tryptophan and the dynamics of its concentration in the blood of patients]. Balakleevskiĭ AI; Mitiukova TA; Vazhenin MM; Gaĭduk FM Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):95-7. PubMed ID: 6112836 [No Abstract] [Full Text] [Related]
11. Decreased extrapyramidal side effects and polypsichopharmacy in family practice outpatients. Holt RJ Bol Asoc Med P R; 1983 Aug; 75(8):351-2. PubMed ID: 6139115 [No Abstract] [Full Text] [Related]
13. A controlled trial of amantadine in drug-induced extrapyramidal disorders. DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE Psychopharmacol Bull; 1977 Jul; 13(3):31-3. PubMed ID: 18755 [No Abstract] [Full Text] [Related]
14. Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate. Dom R; Van Lommel R; Baro F Acta Psychiatr Scand; 1973; 49(5):563-9. PubMed ID: 4148581 [No Abstract] [Full Text] [Related]
15. [Management of neuroleptic side-effects with piracetam (author's transl)]. Sikora J; Kabes J; Pisvejc J Cesk Psychiatr; 1981 Apr; 77(2):137-42. PubMed ID: 6114800 [No Abstract] [Full Text] [Related]
16. [Extrapyramidal motor side-effects and blood profile changes. Stumbling blocks in psychiatric pharmacotherapy]. Grohmann R; Hippius H; Rüther E MMW Fortschr Med; 2001 May; 143 Suppl 2():76-7. PubMed ID: 11434265 [No Abstract] [Full Text] [Related]
17. Reversal of morphine with naloxone precipitates haloperidol-induced extrapyramidal side effects. Guo SL; Lin CJ; Huang HH; Chen LK; Sun WZ J Pain Symptom Manage; 2006 May; 31(5):391-2. PubMed ID: 16716869 [No Abstract] [Full Text] [Related]
18. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents]. Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377 [TBL] [Abstract][Full Text] [Related]
19. [Neuroleptics and extrapyramidal effects from the biochemical viewpoint. Discussion by the Workshop on Neuroleptics and the Extrapyramidal System]. Seyfried C Arzneimittelforschung; 1978; 28(9):1537-8. PubMed ID: 38815 [No Abstract] [Full Text] [Related]